C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
11/2006
11/07/2006	US7132420 Aspartic protease inhibitors
11/07/2006	US7132417 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents
11/07/2006	CA2416879C Methods of treating cancer and the pain associated therewith using endothelin antagonists
11/07/2006	CA2274093C Substituted pyrimidinone and pyridinone compounds and their use
11/07/2006	CA2200578C N-substituted piperidinyl bicyclic benzoate derivatives
11/07/2006	CA2146961C Heterobicyclic sulfonamide and sulfonic ester derivatives
11/07/2006	CA2132132C Process for the preparation of 3-arylbenzofuranones
11/02/2006	WO2006116713A1 Substituted amide derivatives as protein kinase inhibitors
11/02/2006	WO2006115134A1 Novel benzofuran derivative, pharmaceutical composition comprising the same, and use of the derivative or composition
11/02/2006	WO2006114966A1 Organic electroluminescent device, display and illuminating device
11/02/2006	WO2006114371A1 Novel compounds for treating inflammatory diseases
11/02/2006	WO2006114313A1 Pyrazole compounds as prostaglandin receptors ligands
11/02/2006	WO2006114272A1 FURAN COMPOUNDS USEFUL AS EPl RECEPTOR ANTAGONISTS
11/02/2006	WO2006114260A1 Phenylacetylene derivatives having mglur5 receptor affinity
11/02/2006	WO2006114202A1 Method for the production of 5-(4-[4-(5-cyano-3-indolyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide
11/02/2006	WO2006091428A3 Heteroaryl substituted pyrazinyl-piperazine-piperidines with cxcr3 antagonist activity
11/02/2006	WO2006088921A3 Pyrazinyl substituted piperazine-piperidines with cxcr3 antagonist activity
11/02/2006	WO2006088919A3 Pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity
11/02/2006	US20060247448 zearalenone-like macrolides, used to to inhibit nuclear factor kappa-beta (NF- kappa B) activation, as sucnscreen agents and in the treatment of inflammatory or autoimmune disorders and disorders involving malignancy or increased angiogenesis
11/02/2006	US20060247442 Process for preparing isatins with control of side-product formation
11/02/2006	US20060247439 Mchir antagonists
11/02/2006	US20060247305 Chromen-4-one inhibitors of anti-apoptotic Bcl-2 family members and the uses thereof
11/02/2006	US20060247295 1,2,9,9a-tetrahydrocyclopropa[c]benz[e]indole-4-one (CBI) with incorporated alkylating domain; in vivo drug-cleavable substrate conjugates that are potent cytotoxins; antiproliferative, anticarcinogenic agent; leukemia; bone marrow and mucosal toxicity; chronic cardiac and neurological toxicity
11/02/2006	US20060247290 Derivatives of dioxan-2-alkyl carbamates, preparation thereof and application thereof in therapeutics
11/02/2006	US20060247283 5-(3,3-Dichloroprop-2-enyloxy)-2-[4-(2,2-dimethylbenzo[d]1,3-dioxolan-4-yloxy)butoxy]-1,3-dichlorobenzene; acaricides
11/02/2006	US20060247280 Non-peptide, reversible inhibitors of type 2 methionine aminopeptidase, useful in treating conditions mediated by angiogenesis, such as cancer, haemangioma, proliferative retinopathy, rheumatoid arthritis, atherosclerotic neovascularization, psoriasis; 3-Benzyl-5-(benzylthio)-1,2,4-triazole
11/02/2006	US20060247276 Benzofuranyl alkanamine derivatives and uses thereof
11/02/2006	US20060247273 Carbamoyl-type benzofuran derivatives
11/02/2006	US20060247262 2,4 Di (hetero) -arylamino-pyrimidine derivatives as ZAP-70 and/or syk inhibitors
11/02/2006	US20060247259 Urea derivatives containing aromatic or heteroaromatic rings; 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide; prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective
11/02/2006	US20060247249 Carboximide derivatives as useful uro-selective alpha-1a adrenoceptor blockers
11/02/2006	US20060247247 Pyrazole-amine compounds useful as kinase inhibitors
11/02/2006	US20060247242 Pesticidal compositions
11/02/2006	US20060247241 2,4-Di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders
11/02/2006	US20060247230 chemokines receptor modulators such as 4-(2-ethyl-6-fluoro-3-{1-[3-(4-fluoro-phenylsulfanyl)-propyl]-piperidin-4-yl}-indol-1-yl)-benzoic acid ethyl ester, used for treating inflammatory diseases such as asthma and allergic diseases, autoimmune pathologies such as rheumatoid arthritis and atherosclerosis
11/02/2006	US20060247228 Phenylazole compounds production process and antioxidants
11/02/2006	US20060247225 e.g. (1 alpha ,5 alpha ,6 alpha )-N-[3-(4-methyl-3-pentenyl)-3-azabicyclo[3.1.0]hex-6-yl]-2-hydroxy-2-cyclopentyl-2-(4-methoxy)phenylacetamide; respiratory, urinary and gastrointestinal systems disorder; antidiabetic agent
11/02/2006	US20060247224 Melanocortin receptor ligands
11/02/2006	US20060247212 Heterocyclic compounds having inhibitory activity against HIV integrase
11/02/2006	EP1717229A1 Novel cyclic compound having 4-pyridylalkylthio group having (un)substituted amino introduced therein
11/02/2006	EP1717227A1 Substituted indole compounds, their preparation and use in medicaments
11/02/2006	EP1717226A1 2,7-substituted 5-amino-4-hydroxy-8-(1h-indol-5-yl)-octan amide derivatives as renin inhibitors for the treatment of hypertension
11/02/2006	EP1717225A1 Bicyclic amide derivatives
11/02/2006	EP1717220A2 Vanilloid receptor ligands and their use in treatments
11/02/2006	EP1716141A1 Benzopyran derivatives, method of production and use thereof
11/02/2006	EP1716140A1 Coupling reactions useful in the preparation of (1h-tetrazol-5-yl)-biphenyl derivatives
11/02/2006	EP1716134A1 Amino heterocyclic modulators of chemokine receptor activity
11/02/2006	EP1716133A1 2-(piperidin-4-yl)-4,5-dihydro-2h-pyridazin-3-one derivatives as pde4 inhibitors
11/02/2006	EP1716130A1 Acetylinic piperazine compounds and their use as metabotropic glutamate receptor antagonists
11/02/2006	EP1716122A1 Modulators of atp-binding cassette transporters
11/02/2006	EP1716100A2 Therapeutic amide derivatives
11/02/2006	EP1715867A1 Bipyridyl amides as modulators of metabotropic glutamate receptor-5
11/02/2006	EP1715862A1 Kinase inhibitors
11/02/2006	EP1406620B1 Vinyl phenyl derivatives as glk activators
11/02/2006	EP1395568B1 4-aminopyrimidine derivatives
11/02/2006	EP1244446B1 Thrombopoietin mimetics
11/02/2006	EP1202976B1 Pyrazinones, compositions containing such compounds
11/02/2006	EP1194144B1 Antibacterial compounds
11/02/2006	EP1192133B1 N-cyclopentyl modulators of chemokine receptor activity
11/02/2006	EP1143959B1 Antifungal activity of dicationic molecules
11/02/2006	EP1058686B1 2'-fluoronucleosides
11/02/2006	EP1003721B1 Benzylidene-1,3-dihydro-indol-2-one derivatives as receptor tyrosine kinase inhibitors, particularly of raf kinases
11/02/2006	EP0885883B1 Fused heterocyclic compounds and pharmaceutical applications thereof
11/02/2006	EP0821683B1 Benzimidazole compounds and their use as modulators of the gaba a receptor complex
11/02/2006	DE102005020331A1 New 5-substituted quinoline and isoquinoline derivatives are glucocorticoid receptor binders useful for treating inflammatory diseases e.g. alveolitis, Sjogren's syndrome, atopic dermatitis, acute lymphatic leukemia, rhinitis and emesis
11/02/2006	DE102005019670A1 Preparation of 5-(4-(4-(5-cyano-3-indolyl)-butyl)-1-piperazinyl)-benz ofuran-2-carboxamide, comprises reacting a heterocyclic compound with a carbonitrile compound; and/or converting the obtained benzofuran compound to its salt
11/02/2006	DE102005018025A1 New heterocyclic compounds which are cytokine interleukin-8 inhibitors useful for treating e.g., chronic obstructive lung disease, bronchitis, rheumatoid arthritis, psoriasis, gastrointestinal disease and Crohn's disease
11/02/2006	CA2605758A1 Process for the preparation of 5-(4-(4-(5-cyano-3-indolyl)butyl)-1-piperaz-lnyl)benzofuran-2-carboxamide
11/02/2006	CA2605262A1 Phenylacetylene derivatives having mglur5 receptor affinity
11/01/2006	CN1856488A Carbamoyl-type benzofuran derivatives
11/01/2006	CN1856478A Bicyclic imino acid derivatives as inhibitors of matrix metalloproteinases
11/01/2006	CN1856477A 异喹啉钾通道抑制剂 Isoquinoline potassium channel inhibitors
11/01/2006	CN1856474A Isoquinolinone potassium channel inhibitors
11/01/2006	CN1856249A Pyridyl pyrimidines for use as pesticides
11/01/2006	CN1854135A Heteronuclear compound with dicyandiamide connection and its medicinal use
11/01/2006	CN1854134A Piperazine derivatives and their use as serotonin reuptake inhibitors or as neurokinin antagonists
11/01/2006	CN1854128A Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
11/01/2006	CN1853630A Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
10/2006
10/31/2006	US7129359 for treating infection by enterovirus of the Picornaviridae family ; exemplified by: 1-[2-(4'-Chloro-biphenyl-4-yloxymethyl)-benzyl]-3-pyridin-4-yl-imidazolidin-2-one
10/31/2006	US7129350 Coupling process and intermediates useful for preparing cephalosporins
10/31/2006	US7129261 Cytotoxic agents
10/31/2006	US7129260 Isoindolinone kinase inhibitors
10/31/2006	US7129255 Substituted 2-carba-3,5-dicyano-4-aryl-6-aminopyridines and the use of the same as selective ligands of the adenosine receptor
10/31/2006	US7129254 highly active active agents from the structural class of the epothilones and epothilone derivatives with suitable linkers; to link these epothilone-linker conjugates to recognition units, such as, for example, monoclonal antibodies or fragments thereof, to form immune conjugates
10/31/2006	US7129253 Compounds
10/31/2006	US7129247 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
10/31/2006	US7129245 Anticoagulants which act selectively on factor Xa; fast acting; oral; do not interfere with lysis of blood clots
10/31/2006	US7129242 Such as 4-((4-chlorophenyl)pyrimidin-2-yl)amino)benzamide; for treatment of inflammation/autoimmune conditions
10/31/2006	US7129240 1,3-dihydro-2H-indol-2one derivatives, process for preparing them and pharmaceutical compositions containing them
10/31/2006	US7129236 For therapy of immune related responses, tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis
10/31/2006	US7129235 Amides useful for treating pain
10/31/2006	US7129228 Heterocyclic analgesic compounds and methods of use thereof
10/31/2006	CA2355886C Substituted oximes and hydrazones as neurokinin antagonists
10/31/2006	CA2276455C Phthalazinones
10/31/2006	CA2276310C Process for the production of tetrazolylbenzopyrans
10/31/2006	CA2191759C Formylaminophenylsulfonylureas, preparation processes and use as herbicides and plant growth regulators
10/26/2006	WO2006113864A2 Oxindole compounds and their uses as therapeutic agents
10/26/2006	WO2006113704A2 Subtituted heteroaryl cb1 antagonists
10/26/2006	WO2006112479A1 Nitrogen-containing heterocyclic compound
10/26/2006	WO2006112442A1 Benzimidazole compound

1 ... 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 ... 694